Medication info
Ibisdil Tablet 150 mg (Irbesartan)

Ibisdil Tablet 150 mg (Irbesartan)

Prescription medicationTabletOral
Ingredient · strength
Irbesartan›150mg / 1 tablet
Manufacturer / importer
Anguk Pharmaceutical Co., Ltd.
Appearance
White oval film-coated tablets
Packaging
30 tablets per bottle
Approval status
Active

MFDS item code 200703852 · Notified 2007.04.04 · Insurance code 650201450

Summary

Main use
Treatment of essential hypertension and diabetic nephropathy in patients with hypertension and type 2 diabetes
Who takes it
Adults
Adult dose
This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Ingredients

Manufacturer
Anguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension and diabetic nephropathy in patients with hypertension and type 2 diabetes

  • Essential hypertension
  • hypertension
  • kidney disease in patients with type 2 diabetes
View approved original text

This medication is used to treat essential hypertension. Additionally, as part of hypertension therapy, it helps to slow the progression of kidney disease in patients with type 2 diabetes who have hypertension. Therefore, it is effective in improving not only blood pressure control but also kidney health in diabetic patients.

How to take

Adult dose

This medicine may be taken with or without food. 1. Essential hypertension Adults: Administer irbesartan orally at a dose of 150 mg once daily. If the effect is insufficient, the dose may be increased to 300 mg. In general, blood pressure control over 24 hours is better with 150 mg once daily than with 75 mg once daily; however, 75 mg may be considered in special circumstances (e.g., at the start of treatment, in patients receiving hemodialysis, or in patients aged 75 years or older). If blood pressure is not adequately controlled with monotherapy, another antihypertensive agent may be coadministered. The effect is increased particularly when coadministered with a low-dose diuretic (e.g., hydrochlorothiazide). 2. Nephropathy in patients with type 2 diabetes and hypertension Adults: It is recommended to start oral administration of this medicine at 150 mg once daily and increase the dose to 300 mg for maintenance. If necessary, another antihypertensive agent may be coadministered to achieve the target blood pressure. ○ Older adults Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients aged 75 years or older. ○ Patients with renal impairment Dose adjustment is generally not necessary; however, a starting dose of 75 mg should be considered in patients receiving hemodialysis. ○ Patients with hepatic impairment Although no specific dose adjustment is generally necessary in patients with mild to moderate hepatic impairment, it is recommended that the dose not exceed 150 mg daily. There is no clinical experience in patients with severe hepatic impairment.

Precautions

This medication can cause serious harm to the fetus, especially during pregnancy, therefore, it should not be taken by women who are pregnant or may become pregnant. If pregnancy is confirmed, the medication should be discontinued immediately. It should not be administered to patients with allergy reactions to this drug, severe liver impairment, specific renal diseases, or a history of angioedema. Elderly patients, those with elevated serum potassium levels, those with impaired liver function, and those with heart disease should use this medication with caution and require regular monitoring according to medical advice. Generally, side effects of this medication are mild and temporary, but dizziness, headaches, cough, indigestion, etc., may occur, and rarely serious side effects such as angioedema, hyperkalemia, liver dysfunction, and renal failure can occur, so caution is required. This medication can be taken with other antihypertensive medications; however, patients should be cautious as potassium supplements or potassium-sparing diuretics may lead to dangerously elevated potassium levels in the blood. When taken with lithium or non-steroidal anti-inflammatory drugs, the risk of renal function decline or side effects may increase, so patients should consult their physician. This medication is not recommended for breastfeeding women; it is advisable to discontinue breastfeeding when taking the medication. Safety has not been established for pediatric use, and dosage should start low and be administered with caution in elderly patients. In cases of overdose, hypotension and cardiac arrhythmias may occur; if overdose is suspected, immediate consultation with medical personnel and appropriate treatment is necessary. When storing, keep it out of reach of children, and do not transfer to another container.

Side effects

  • Respiratory infection
  • headache
  • musculoskeletal pain
  • dizziness
  • fatigue
  • diarrhea
  • cough
  • nausea/vomiting
  • musculoskeletal trauma
  • chest pain
Show 107 more
  • indigestion/heartburn
  • edema
  • abdominal pain
  • rash
  • tachycardia
  • anxiety/nervousness
  • upper urinary tract infection
  • fever
  • chills
  • facial edema
  • arm swelling
  • flushing
  • hypertension
  • heart murmur
  • myocardial infarction
  • angina
  • arrhythmia/conduction abnormality
  • cardiac-respiratory arrest
  • heart failure
  • hypertensive crisis
  • itching
  • dermatitis
  • petechiae
  • erythema
  • urticaria
  • sexual dysfunction
  • changes in sexual function
  • gout
  • constipation
  • oral lesions
  • gastroenteritis
  • abdominal distension
  • limb edema
  • muscle stiffness
  • arthritis
  • myalgia
  • chest pain
  • joint stiffness
  • bursitis
  • muscle weakness
  • sleep disorders
  • paralysis
  • hypersomnia
  • mood disorders
  • depression
  • sensory abnormalities
  • tremor
  • transient ischemia
  • cerebrovascular accident
  • abnormal urination
  • prostate abnormalities
  • epistaxis
  • bronchitis
  • congestion
  • pulmonary congestion
  • dyspnea
  • wheezing
  • visual impairment
  • auditory abnormalities
  • ear infection
  • ear pain
  • conjunctivitis
  • eyelid abnormalities
  • ear abnormalities
  • dizziness
  • orthostatic dizziness
  • orthostatic hypotension
  • elevated plasma creatine kinase
  • hyperkalemia
  • hypersensitivity reaction
  • rash
  • urticaria
  • angioedema
  • anaphylactic shock
  • weakness
  • diarrhea
  • dyspepsia
  • nausea
  • tinnitus
  • myalgia
  • elevated plasma creatine kinase
  • arthralgia
  • tachycardia
  • hepatitis
  • liver dysfunction
  • renal failure
  • psoriasis
  • photosensitivity reaction
  • anemia
  • thrombocytopenia
  • hypoglycemia
  • angioedema
  • shock
  • syncope
  • loss of consciousness
  • renal failure
  • liver dysfunction
  • jaundice
  • hypoglycemia
  • rhabdomyolysis
  • myalgia
  • weakness
  • increased creatine kinase
  • elevated myoglobin in blood and urine
  • hypotension
  • tachycardia
  • bradycardia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture; therefore, it should be stored in a sealed container. Additionally, it is important to store it in a cool and dry place below 30 degrees Celsius to maintain the medication's effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets per bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.